newsfilter
← Latest News
GlobeNewswire·

Chembio Diagnostics Receives SAHPRA Approval for DPP SARS-CoV-2 Antigen Test

HAUPPAUGE, N.Y., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced receipt on November 26, 2021, of South Africa Health Products Regu